Neuronal and glial markers are differently associated with computed tomography findings and outcome in patients with severe traumatic brain injury: A case control study

Critical Care

Volumn 15, Issue 3, 2011, Pages

  Mondello, Stefania ^a,b   Papa, Linda ^c   Buki, Andras ^d   Bullock, M Ross ^e   Czeiter, Endre ^d   Tortella, Frank C ^f   Wang, Kevin K ^b,g   Hayes, Ronald L ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b BANYAN BIOMARKERS INC   (United States)

^c ORLANDO REGIONAL MEDICAL CENTER   (United States)

^d UNIVERSITY OF PÉCS   (Hungary)

^e UNIVERSITY OF MIAMI   (United States)

^f WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^g UNIVERSITY OF FLORIDA HEALTH   (United States)

Author keywords

Biomarkers; Computed tomography; Diagnostic; Outcome; Traumatic Brain Injury

Indexed keywords

CELL MARKER; GLIAL FIBRILLARY ACIDIC PROTEIN; UBIQUITIN CARBOXY TERMINAL HYDROLASE L1; UBIQUITIN THIOLESTERASE; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; UCHL1 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEATH; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLASGOW COMA SCALE; GLASGOW OUTCOME SCALE; GLIA CELL; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INJURY SEVERITY; MAJOR CLINICAL STUDY; MALE; NERVE CELL; NEURORADIOLOGY; NEUROTRAUMATOLOGY; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TRAUMATIC BRAIN INJURY; BLOOD; BRAIN INJURY; CASE CONTROL STUDY; CLINICAL TRIAL; COMPARATIVE STUDY; GLIA; HOSPITALIZATION; METABOLISM; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PROSPECTIVE STUDY; RADIOGRAPHY;

ADULT; AGED; BIOLOGICAL MARKERS; BRAIN INJURIES; CASE-CONTROL STUDIES; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; MALE; MIDDLE AGED; NEUROGLIA; NEURONS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED; UBIQUITIN THIOLESTERASE; YOUNG ADULT;

EID: 80052083167     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc10286     Document Type: Article

References (32)

1. Signorini DF, Andrews PJ, Jones PA, Wardlaw JM, Miller JD. Predicting survival using simple clinical variables: a case study in traumatic brain injury. J Neurol Neurosurg Psychiatry 1999, 66:20-25. 10.1136/jnnp.66.1.20, 1736162, 9886445.
2. Marshall LF, Marshall SB, Klauber MR, Van Berkum Clark M, Eisenber HM, Jane JA, Luersse TJ, Marmarou A, Foulkes M. A new classification of head injury based on computerized tomography. J Neurosurg 1991, 75(Suppl):14-20.
3. Maas AI, Hukkelhoven CW, Marshall LF, Steyerberg EW. Prediction of outcome in traumatic brain injury with computed tomographic characteristics: a comparison between the computed tomographic classification and combinations of computed tomographic predictors. Neurosurgery 2005, 57:1173-1182.
4. Bakay RA, Sweeney KM, Wood JH. Pathophysiology of cerebrospinal fluid in head injury: part 2. Biochemical markers for central nervous system trauma. Neurosurgery 1986, 18:376-382. 10.1227/00006123-198603000-00026, 3010171.
5. Tongaonkar P, Chen L, Lambertson D, Ko B, Madura K. Evidence for an interaction between ubiquitin-conjugating enzymes and the 26S proteasome. Mol Cell Biol 2000, 20:4691-4698. 10.1128/MCB.20.13.4691-4698.2000, 85887, 10848595.
6. Papa L, Akinyi L, Liu MC, Pineda JA, Tepas JJ, Oli MW, Zheng W, Robinson G, Robicsek SA, Gabrielli A, Heaton SC, Hannay HJ, Demery JA, Brophy GM, Layon J, Robertson CS, Hayes RL, Wang KK. Ubiquitin C-terminal hydrolase is a novel biomarker in humans for severe traumatic brain injury. Crit Care Med 2010, 38:138-144. 10.1097/CCM.0b013e3181b788ab, 19726976.
7. Pelinka LE, Kroepfl A, Schmidhammer R, Krenn M, Buchinger W, Redl H, Raabe A. Glial fibrillary acidic protein in serum after traumatic brain injury and multiple trauma. J Trauma 2004, 57:1006-1012. 10.1097/01.TA.0000108998.48026.C3, 15580024.
8. Vos PE, Lamers KJ, Hendriks JC, van Haaren M, Beems T, Zimmerman C, van Geel W, de Reus H, Biert J, Verbeek MM. Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury. Neurology 2004, 62:1303-1310.
9. Guidelines for the management of severe traumatic brain injury Brain Trauma Foundation; American Association of Neurological Surgeons; Congress of Neurological Surgeons; Joint Section on Neurotrauma and Critical Care, AANS/CNS. J Neurotrauma 2007, 24(Suppl 1).
10. Raabe A, Grolms C, Keller M, Döhnert J, Sorge O, Seifert V. Correlation of computed tomography findings and serum brain damage markers following severe head injury. Acta Neurochir (Wien) 1998, 140:787-791. discussion 791-922, 10.1007/s007010050180, 9810445 .
11. Choi SC, Clifton GL, Marmarou A, Miller ER. Misclassification and treatment effect on primary outcome measures in clinical trials of severe neurotrauma. J Neurotrauma 2002, 19:17-22. 10.1089/089771502753460204, 11852975.
12. Adams JH. Head injury. Greenfield's Neuropathology 1992, 106-152. New York: Oxford University Press, Adams JH, Cuchen LW, 5.
13. Graham DI. Neuropathology of head injury. Neurotrauma 1996, 43-59. New York: McGrawHill, Narayan RK, Wilberger JE, Povlishock JT.
14. Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: An integrated view. Trends Neurosci 1999, 22:391-397. 10.1016/S0166-2236(99)01401-0, 10441299.
15. Heiss WD, Rosner G. Functional recovery of cortical neurons as related to degree and duration of ischemia. Ann Neurol 1983, 14:294-301. 10.1002/ana.410140307, 6314871.
16. Dietrich WD, Alonso O, Halley M. Early microvascular and neuronal consequences of traumatic brain injury: A light and electron microscopic study in rats. J Neurotrauma 1994, 11:289-301. 10.1089/neu.1994.11.289, 7996583.
17. Adams JH, Graham DI, Jennett B. The structural basis of moderate disability after traumatic brain damage. J Neurol Neurosurg Psychiatry 2001, 71:521-524. 10.1136/jnnp.71.4.521, 1763517, 11561038.
18. Blumbergs PC, Scott G, Manavis J, Wainwright H, Simpson DA, McLean AJ. Staining of amyloid precursor protein to study axonal damage in mild head injury. Lancet 1994, 344:1055-1056. 10.1016/S0140-6736(94)91712-4, 7523810.
19. Adams JH, Jennett B, McLellan DR, Murray LS, Graham DI. The neuropathology of the vegetative state after head injury. J Clin Pathol 1999, 52:804-806. 10.1136/jcp.52.11.804, 501589, 10690167.
20. Raabe A, Grolms C, Sorge O, Zimmermann M, Seifert V. Serum S-100B protein in severe head injury. Neurosurgery 1999, 45:477-483. 10.1097/00006123-199909000-00012, 10493369.
21. Mushkudiani NA, Engel DC, Steyerberg EW, Butcher I, Lu J, Marmarou A, Slieker F, McHugh GS, Murray GD, Maas AI. Prognostic value of demographic characteristics in traumatic brain injury: results from the IMPACT study. J Neurotrauma 2007, 24:259-269. 10.1089/neu.2006.0028, 17375990.
22. Farace E, Habbema JD, Marshall LF, Murray GD, Maas AI. Patient age and outcome following severe traumatic brain injury: an analysis of 5600 patients. J Neurosurg 2003, 99:666-673. 10.3171/jns.2003.99.4.0666, 14567601.
23. Vos PE, Verbeek MM. Brain specific proteins in serum: do they reliably reflect brain damage?. Shock 2002, 18:481-482. 10.1097/00024382-200211000-00017, 12412631.
24. Wardlaw JM, Easton VJ, Statham P. Which CT features help predict outcome after head injury?. J Neurol Neurosurg Psychiatry 2002, 72:188-192. 10.1136/jnnp.72.2.188, 1737755, 11796768.
25. Tsacopoulos M, Magistretti PJ. Metabolic coupling between glia and neurons. J Neurosci 1996, 16:877-885.
26. Chen Y, Swanson RA. Astrocytes and brain injury. J Cereb Blood Flow Metab 2003, 23:137-149. 12571445, 12571445.
27. Wiesmann M, Steinmeier E, Magerkurth O, Linn J, Gottmann D, Missler U. Outcome prediction in traumatic brain injury: comparison of neurological status, CT findings, and blood levels of S100B and GFAP. Acta Neurol Scand 2010, 121:178-185. 10.1111/j.1600-0404.2009.01196.x, 19804476.
28. McKeating EG, Andrews PJ, Mascia L. Relationship of neuron specific enolase and protein S-100 concentrations in systemic and jugular venous serum to injury severity and outcome after traumatic brain injury. Acta Neurochir Suppl 1998, 71:117-119. 9779161, 9779161 .
29. Ingebrigtsen T, Romner B, Marup-Jensen S, Dons M, Lundqvist C, Bellner J, Alling C, Børgesen SE. The clinical value of serum S-100 protein measurements in minor head injury: a Scandinavian multicentre study. Brain Inj 2000, 14:1047-1055. 10.1080/02699050050203540, 11147577.
30. Lobato RD, Cordobes F, Rivas JJ, de la Fuente M, Montero A, Barcena A, Perez C, Cabrera A, Lamas E. Outcome from severe head injury related to the type of intracranial lesion: A computerized tomography study. J Neurosurg 1983, 59:762-774. 10.3171/jns.1983.59.5.0762, 6619928.
31. Servadei F, Murray GD, Penny K. The value of the worst computed tomographic scan in clinical studies of moderate and severe head injury. Neurosurgery 2000, 46:70-77.
32. Manolio T. Novel risk markers and clinical practice. N Engl J Med 2003, 349:1587-1589. 10.1056/NEJMp038136, 14573728.